With over 10 million cases and over 5.7 million deaths a year (GLOBOCAN data 2002; Ferlay et al. 2004), cancer presents a major health problem worldwide. Dealing with cancer, both from a clinical and from a fundamental scientific view, is complicated by the extensive diversity within this disease. Based on their origin, more than 100 different human cancer types have been described and, within one organ, distinct subtypes can occur. In addition, tumors may progress to a malignant state that manifests itself mainly when tumor cells spread out from the primary lesion (or neoplasm) and metastasize, i.e., colonize distant sites of the patient’s body. Metastatic cancer, accounts for 90% of cancer-related lethality (Sporn 1996) and hence forms the primary determining factor in patient outcome. Therefore a detailed molecular understanding of tumor cell spread is required to render treatment of cancer more specific and efficient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adya, N., Stacy, T., Speck, N. A. and Liu, P. P. 1998. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Mol. Cell. Biol. 18, 7432-7443.
Ahmed, F., Wyckoff, J., Lin, E. Y., Wang, W., Wang, Y., Hennighausen, L., Miyazaki, J., Jones, J., Pollard, J. W., Condeelis, J. S. and Segall, J. E. 2002. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res. 62, 7166-7169.
Al-Nedawi, K. N., Czyz, M., Bednarek, R., Szemraj, J., Swiatkowska, M., Cierniewska-Cieslak, A., Wyczolkowska, J. and Cierniewski, C. S. 2004. Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression. Blood 103, 1319-1324.
Alldinger, I., Dittert, D., Peiper, M., Fusco, A., Chiappetta, G., Staub, E., Lohr, M., Jesnowski, R., Baretton, G., Ockert, D., Saeger, H. D., Grutzmann, R. and Pilarsky, C. 2005. Gene expression analysis of pancreatic cell lines reveals genesoverexpressed in pancreatic cancer. Pancreatology 5, 370-379.
Amsellem, V., Kryszke, M. H., Hervy, M., Subra, F., Athman, R., Leh, H., BrachetDucos, C. and Auclair, C. 2005. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Exp. Cell Res. 304, 443-456.
Anderson, K. I., Wang, Y. L. and Small, J. V. 1996. Coordination of protrusion and translocation of the keratocyte involves rolling of the cell body. J. Cell Biol. 134, 1209-1218.
Anilkumar, G., Rajasekaran, S. A., Wang, S., Hankinson, O., Bander, N. H. and Rajasekaran, A. K. 2003. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res. 63, 2645-2648.
Asch, H. L., Winston, J. S., Edge, S. B., Stomper, P. C. and Asch, B. B. 1999. Downregulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res. Treat. 55, 179-188.
Bagheri-Yarmand, R., Mazumdar, A., Sahin, A. A. and Kumar, R. 2006. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int. J. Cancer 118, 2703-2710.
Bajou, K., Noel, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D. and Foidart, J. M. 1998. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med. 4, 923-928.
Ballestrem, C., Hinz, B., Imhof, B. A. and Wehrle-Haller, B. 2001. Marching at the front and dragging behind: Differential alphaVbeta3-integrin turnover regulates focal adhesion behavior. J. Cell Biol. 155, 1319-1332.
Bao, L., Loda, M., Janmey, P. A., Stewart, R., Anand-Apte, B. and Zetter, B. R. 1996. Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat. Med. 2, 1322-1328.
Bao, L., Loda, M. and Zetter, B. R. 1998. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin. Exp. Metastasis 16, 227-233.
Barzik, M., Kotova, T. I., Higgs, H. N., Hazelwood, L., Hanein, D., Gertler, F. B. and Schafer, D. A. 2005. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J. Biol. Chem. 280, 28653-28662.
Berx, G. and Van Roy, F. 2001. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3, 289-293.
Blain, E. J., Mason, D. J. and Duance, V. C. 2002. The effect of thymosin beta4 on articular cartilage chondrocyte matrix metalloproteinase expression. Biochem. Soc. Trans. 30, 879-882.
Boccellino, M., Giuberti, G., Quagliuolo, L., Marra, M., D’Alessandro, A. M., Fujita, H., Giovane, A., Abbruzzese, A. and Caraglia, M. 2004. Apoptosis induced by interferon-alpha and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells. J. Cell. Physiol. 201, 71-83.
Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M. and Srivastava, D. 2004. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466-472.
Bossis, I. and Stratakis, C. A. 2004. PRKAR1A: Normal and abnormal functions. Endocrinology 145, 5452-5458.
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. and Kirchner, T. 2005. Opinion: Migrating cancer stem cells - An integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749.
Braverman, R. H., Cooper, H. L., Lee, H. S. and Prasad, G. L. 1996. Anti-oncogenic effects of tropomyosin: Isoform specificity and importance of protein coding sequences. Oncogene 13, 537-545.
Brunton, V. G., MacPherson, I. R. and Frame, M. C. 2004. Cell adhesion receptors, tyrosine kinases and actin modulators: A complex three-way circuitry. Biochim. Biophys. Acta 1692, 121-144.
Bryce, N. S., Clark, E. S., Leysath, J. L., Currie, J. D., Webb, D. J. and Weaver, A. M. 2005. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr. Biol. 15, 1276-1285.
Buccione, R., Orth, J. D. and McNiven, M. A. 2004. Foot and mouth: Podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell. Biol. 5, 647-657.
Budhu, A. S., Zipser, B., Forgues, M., Ye, Q. H., Sun, Z. and Wang, X. W. 2005. The molecular signature of metastases of human hepatocellular carcinoma. Oncology 69 (Suppl. 1), 23-27.
Burridge, K. and Wennerberg, K. 2004. Rho and Rac take center stage. Cell 116, 167-179.
Carmeci, C., Thompson, D. A., Kuang, W. W., Lightdale, N., Furthmayr, H. and Weigel, R. J. 1998. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype. Surgery 124, 211-217.
Carmeliet, P. 2005. VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl. 3), 4-10.
Cha, H. J., Jeong, M. J. and Kleinman, H. K. 2003. Role of thymosin beta4 in tumor metastasis and angiogenesis. J. Natl Cancer Inst. 95, 1674-1680.
Chakravatri, A., Zehr, E. M., Zietman, A. L., Shipley, W. U., Goggins, W. B., Finkelstein, D. M., Young, R. H., Chang, E. L. and Wu, C. L. 2000. Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer - Results from a pilot study. Urology 55, 635-638.
Chandrasekar, I., Stradal, T. E., Holt, M. R., Entschladen, F., Jockusch, B. M. and Ziegler, W. H. 2005. Vinculin acts as a sensor in lipid regulation of adhesion-site turnover. J. Cell Sci. 118, 1461-1472.
Chaponnier, C. and Gabbiani, G. 1989. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma. Am. J. Pathol. 134, 597-603.
Chaponnier, C. and Gabbiani, G. 2004. Pathological situations characterized by altered actin isoform expression. J. Pathol. 204, 386-395.
Chiappetta, G., Pentimalli, F., Monaco, M., Fedele, M., Pasquinelli, R., Pierantoni, G. M., Ribecco, M. T., Santelli, G., Califano, D., Pezzullo, L. and Fusco, A. 2004. Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias. Oncol. Rep. 12, 239-243.
Chitaley, K., Chen, L., Galler, A., Walter, U., Daum, G. and Clowes, A. W. 2004. Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett. 556, 211-215.
Chu, Y. S., Thomas, W. A., Eder, O., Pincet, F., Perez, E., Thiery, J. P. and Dufour, S. 2004. Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. J. Cell Biol. 167, 1183-1194.
Chuma, M., Sakamoto, M., Yasuda, J., Fujii, G., Nakanishi, K., Tsuchiya, A., Ohta, T., Asaka, M. and Hirohashi, S. 2004. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol. 41, 629-636.
Clark, E. A., Golub, T. R., Lander, E. S. and Hynes, R. O. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535.
Coello, M. C., Luketich, J. D., Litle, V. R. and Godfrey, T. E. 2004. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin. Lung Cancer 5, 214-225.
Condeelis, J. 1993. Understanding the cortex of crawling cells: Insights from Dictyostelium. Trends Cell Biol. 3, 371-376.
Condeelis, J. and Segall, J. E. 2003. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 3, 921-930.
Condeelis, J., Singer, R. H. and Segall, J. E. 2005. The great escape: When cancer cells hijack the genes for chemotaxis and motility. Annu. Rev. Cell Dev. Biol. 21, 695-718.
Critchley, D. R. 2004. Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. Biochem. Soc. Trans. 32, 831-836.
Cunningham, C. C., Stossel, T. P. and Kwiatkowski, D. J. 1991. Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 251, 1233-1236.
Curto, M. and McClatchey, A. I. 2004. Ezrin, a metastatic detERMinant? Cancer Cell 5,113-114.
Daly, R. J. 2004. Cortactin signalling and dynamic actin networks. Biochem. J. 382, 13-25.
Dang, D., Bamburg, J. R. and Ramos, D. M. 2006. Alphavbeta3 integrin and cofilin modulate K1735 melanoma cell invasion. Exp. Cell Res. 312, 468-477.
Davila, M., Frost, A. R., Grizzle, W. E. and Chakrabarti, R. 2003. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: Implications in prostate cancer. J. Biol. Chem. 278, 36868-36875.
De Corte, V., Bruyneel, E., Boucherie, C., Mareel, M., Vandekerckhove, J. and Gettemans, J. 2002. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J. 21, 6781-6790.
De Corte, V., Gettemans, J. and Vandekerckhove, J. 1997. Phosphatidylinositol 4, 5-bisphosphate specifically stimulates PP60(c-src) catalyzed phosphorylation of gelsolin and related actin-binding proteins. FEBS Lett. 401, 191-196.
De Corte, V., Van Impe, K., Bruyneel, E., Boucherie, C., Mareel, M., Vandekerckhove, J. and Gettemans, J. 2004. Increased importin-beta-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J. Cell Sci. 117, 5283-5292.
De Craene, B., Gilbert, B., Stove, C., Bruyneel, E., van Roy, F. and Berx, G. 2005. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res. 65, 6237-6244.
De Ganck, A., Hubert, T., Van Impe, K., Geelen, D., Vandekerckhove, J., De Corte, V. and Gettemans, J. 2005. A monopartite nuclear localization sequence regulates nuclear targeting of the actin binding protein myopodin. FEBS Lett. 579, 6673-6680.
De Wever, O., Nguyen, Q. D., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C. and Mareel, M. 2004a. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016-1018.
De Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach, C., Bruyneel, E. and Mareel, M. 2004b. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J. Cell Sci. 117, 4691-4703.
Delanote, V., Vandekerckhove, J. and Gettemans, J. 2005. Plastins: Versatile modulators of actin organization in (patho)physiological cellular processes. Acta Pharmacol. Sin. 26, 769-779.
Dertsiz, L., Ozbilim, G., Kayisli, Y., Gokhan, G. A., Demircan, A. and Kayisli, U. A. 2005. Differential expression of VASP in normal lung tissue and lung adenocarcinomas. Thorax 60, 576-581.
DesMarais, V., Ghosh, M., Eddy, R. and Condeelis, J. 2005. Cofilin takes the lead. J. Cell Sci. 118, 19-26.
DesMarais, V., Macaluso, F., Condeelis, J. and Bailly, M. 2004. Synergistic interaction between the Arp2/3 complex and cofilin drives stimulated lamellipod extension. J. Cell Sci. 117, 3499-3510.
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A. and Chinnaiyan, A. M. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826.
Di Modugno, F., Bronzi, G., Scanlan, M. J., Del Bello, D., Cascioli, S., Venturo, I., Botti, C., Nicotra, M. R., Mottolese, M., Natali, P. G., Santoni, A., Jager, E. and Nistico, P. 2004. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int. J. Cancer 109, 909-918.
Ding, S. J., Li, Y., Shao, X. X., Zhou, H., Zeng, R., Tang, Z. Y. and Xia, Q. C. 2004. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 4, 982-994.
Dong, Y., Asch, H. L., Ying, A. and Asch, B. B. 2002. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells. Exp. Cell Res. 276, 328-336.
Dosaka-Akita, H., Hommura, F., Fujita, H., Kinoshita, I., Nishi, M., Morikawa, T., Katoh, H., Kawakami, Y. and Kuzumak, N. 1998. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 58, 322-327.
Edwards, D. C., Sanders, L. C., Bokoch, G. M. and Gill, G. N. 1999. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1, 253-259.
Elliott, B. E., Meens, J. A., SenGupta, S. K., Louvard, D. and Arpin, M. 2005. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 7, 365-373.
Everley, P. A., Krijgsveld, J., Zetter, B. R. and Gygi, S. P. 2004. Quantitative cancer proteomics: Stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol. Cell Proteomics 3, 729-735.
Faix, J. and Rottner, K. 2006. The making of filopodia. Curr. Opin. Cell Biol. 18, 18-25.
Falet, H., Hoffmeister, K. M., Neujahr, R., Italiano, J. E., Jr., Stossel, T. P., Southwick, F. S. and Hartwig, J. H. 2002. Importance of free actin filament barbed ends for Arp2/3 complex function in platelets and fibroblasts. Proc. Natl Acad. Sci. USA 99, 16782-16787.
Farina, K. L., Wyckoff, J. B., Rivera, J., Lee, H., Segall, J. E., Condeelis, J. S. and Jones, J. G. 1998. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res. 58, 2528-2532.
Ferlay, J., Bray, F., Pisani, P. and Parkin, D. M. 2004. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARCPress, Lyon.
Flanagan, L. A., Chou, J., Falet, H., Neujahr, R., Hartwig, J. H. and Stossel, T. P. 2001. Filamin A, the Arp2/3 complex and the morphology and function of cortical actin filaments in human melanoma cells. J. Cell Biol. 155, 511-517.
Franca-Koh, J. and Devreotes, P. N. 2004. Moving forward: Mechanisms of chemoattractant gradient sensing. Physiology 19, 300-308.
Franco, S. J. and Huttenlocher, A. 2005. Regulating cell migration: Calpains make the cut. J. Cell Sci. 118, 3829-3838.
Friedl, P. 2004. Prespecification and plasticity: Shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16, 14-23.
Friedl, P., Borgmann, S. and Brocker, E. B. 2001. Amoeboid leukocyte crawling through extracellular matrix: Lessons from the Dictyostelium paradigm of cell movement. J. Leukoc. Biol. 70, 491-509.
Friedl, P. and Brocker, E. B. 2000. The biology of cell locomotion within threedimensional extracellular matrix. Cell. Mol. Life Sci. 57, 41-64.
Friedl, P., Hegerfeldt, Y. and Tusch, M. 2004. Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 48, 441-449.
Friedl, P., Maaser, K., Klein, C. E., Niggemann, B., Krohne, G. and Zanker, K. S. 1997. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res. 57, 2061-2070.
Friedl, P. and Wolf, K. 2003. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem. Soc. Symp. 70, 277-285.
Fujita, H., Okada, F., Hamada, J., Hosokawa, M., Moriuchi, T., Koya, R. C. and Kuzumaki, N. 2001. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int. J. Cancer 93, 773-780.
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M. R. 2004. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183.
Galiegue-Zouitina, S., Quief, S., Hildebrand, M. P., Denis, C., Detourmignies, L., Lai, J. L. and Kerckaert, J. P. 1999. Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma. Genes Chromosomes Cancer 26, 97-105.
Gamba, A., de Candia, A., Di Talia, S., Coniglio, A., Bussolino, F. and Serini, G. 2005. Diffusion-limited phase separation in eukaryotic chemotaxis. Proc. Natl Acad. Sci. USA 102, 16927-16932.
Gautreau, A., Manent, J., Fievet, B., Louvard, D., Giovannini, M. and Arpin, M. 2002. Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway. J. Biol. Chem. 277, 31279-31282.
Gettemans, J., Van Impe, K., Delanote, V., Hubert, T., Vandekerckhove, J. and De Corte, V. 2005. Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6, 847-857.
Giganti, A., Plastino, J., Janji, B., Van Troys, M., Lentz, D., Ampe, C., Sykes, C., and Friederich, E. 2005. Actin-filament cross-linking protein T-plastin increases Arp2/3-mediated actin-based movement. J. Cell Sci. 118, 1255-1265.
Gimona, M., Kazzaz, J. A. and Helfman, D. M. 1996. Forced expression of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic effects. Proc. Natl Acad. Sci. USA 93, 9618-9623.
Glukhova, M., Koteliansky, V., Sastre, X. and Thiery, J. P. 1995. Adhesion systems in normal breast and in invasive breast carcinoma. Am. J. Pathol. 146, 706-716.
Gotoh, A. and Broxmeyer, H. E. 1997. The function of BCR/ABL and related protooncogenes. Curr. Opin. Hematol. 4, 3-11.
Gronborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., Maitra, A. and Pandey, A. 2006. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 5, 157-171.
Grosse, R., Copeland, J. W., Newsome, T. P., Way, M. and Treisman, R. 2003. A role for VASP in RhoA-Diaphanous signalling to actin dynamics and SRF activity. EMBO J. 22, 3050-3061.
Gunnersen, J. M., Spirkoska, V., Smith, P. E., Danks, R. A. and Tan, S. S. 2000. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 32, 146-154.
Gunning, P. W., Schevzov, G., Kee, A. J. and Hardeman, E. C. 2005. Tropomyosin isoforms: Divining rods for actin cytoskeleton function. Trends Cell Biol. 15, 333-341.
Gupton, S. L., Anderson, K. L., Kole, T. P., Fischer, R. S., Ponti, A., Hitchcock-DeGregori, S. E., Danuser, G., Fowler, V. M., Wirtz, D., Hanein, D. and WatermanStorer, C. M. 2005. Cell migration without a lamellipodium: Translation of actin dynamics into cell movement mediated by tropomyosin. J. Cell Biol. 168, 619-631.
Gutmann, D. H. 2001. The neurofibromatoses: When less is more. Hum. Mol. Genet. 10,747-755.
Hall, A. K. 1994. Amplification-independent overexpression of thymosin beta-10 mRNA in human renal cell carcinoma. Ren. Fail. 16, 243-254.
Hanahan, D. and Weinberg, R. A. 2000. The hallmarks of cancer. Cell 100, 57-70.
Hashimoto, Y., Skacel, M. and Adams, J. C. 2005. Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker? Int. J. Biochem. Cell Biol. 37, 1787-1804.
Hegerfeldt, Y., Tusch, M., Brocker, E. B. and Friedl, P. 2002. Collective cell movement in primary melanoma explants: Plasticity of cell-cell interaction, beta1-integrin function and migration strategies. Cancer Res. 62, 2125-2130.
Hernandez, S. E., Krishnaswami, M., Miller, A. L. and Koleske, A. J. 2004. How do Abl family kinases regulate cell shape and movement? Trends Cell Biol. 14, 36-44.
Hilpela, P., Vartiainen, M. K. and Lappalainen, P. 2004. Regulation of the actin cytoskeleton by PI(4,5)P2 and PI(3,4,5)P3. Curr. Top. Microbiol. Immunol. 282, 117-163.
Hoffman, R. M. 2005. In vivo cell biology of cancer cells visualized with fluorescent proteins. Curr. Top. Dev. Biol. 70, 121-144.
Honda, K., Yamada, T., Endo, R., Ino, Y., Gotoh, M., Tsuda, H., Yamada, Y., Chiba, H. and Hirohashi, S. 1998. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol. 140, 1383-1393.
Honda, K., Yamada, T., Hayashida, Y., Idogawa, M., Sato, S., Hasegawa, F., Ino, Y., Ono, M. and Hirohashi, S. 2005. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 128, 51-62.
Hou, Y., Gupta, N., Shoenlein, P., Wong, E., Martindale, R., Ganapathy, V. and Browning, D. 2006. An anti-tumor role for cGMP-dependent protein kinase. Cancer Lett. 240, 60-68.
Huber, M. A., Kraut, N. and Beug, H. 2005. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17,548-558.
Huff, T., Muller, C. S., Otto, A. M., Netzker, R. and Hannappel, E. 2001. beta-thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33, 205-220.
Huff, T., Rosorius, O., Otto, A. M., Muller, C. S., Ballweber, E., Hannappel, E. and Mannherz, H. G. 2004. Nuclear localisation of the G-actin sequestering peptide thymosin beta4. J. Cell Sci. 117, 5333-5341.
Hunter, K. W. 2004. Ezrin, a key component in tumor metastasis. Trends Mol. Med. 10,201-204.
Hutchinson, L. M., Chang, E. L., Becker, C. M., Shih, M. C., Brice, M., DeWolf, W. C., Gaston, S. M. and Zetter, B. R. 2005. Use of thymosin beta15 as a urinary biomarker in human prostate cancer. Prostate 64, 116-127.
Huttelmaier, S., Zenklusen, D., Lederer, M., Dictenberg, J., Lorenz, M., Meng, X., Bassell, G. J., Condeelis, J. and Singer, R. H. 2005. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438, 512-515.
Huttenlocher, A., Ginsberg, M. H. and Horwitz, A. F. 1996. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J. Cell Biol. 134, 1551-1562.
Islam, A. H., Ehara, T., Kato, H., Hayama, M. and Nishizawa, O. 2004. Loss of calponin h1 in renal angiomyolipoma correlates with aggressive clinical behavior. Urology 64, 468-473.
Janke, J., Schluter, K., Jandrig, B., Theile, M., Kolble, K., Arnold, W., Grinstein, E., Schwartz, A., Estevez-Schwarz, L., Schlag, P. M., Jockusch, B. M. and Scherneck, S. 2000. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J. Exp. Med. 191, 1675-1686.
Jawhari, A. U., Buda, A., Jenkins, M., Shehzad, K., Sarraf, C., Noda, M., Farthing, M. J., Pignatelli, M. and Adams, J. C. 2003. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am. J. Pathol. 162, 69-80.
Jing, L., Liu, L., Yu, Y. P., Dhir, R., Acquafondada, M., Landsittel, D., Cieply, K., Wells, A. and Luo, J. H. 2004. Expression of myopodin induces suppression of tumor growth and metastasis. Am. J. Pathol. 164, 1799-1806.
Kabukcuoglu, S., Ozalp, S. S., Oner, U., Acikalin, M. F., Yalcin, O. T. and Colak, E. 2005. Fascin, an actin-bundling protein expression in cervical neoplasms. Eur. J. Gynaecol. Oncol. 26, 636-641.
Kaneda, A., Kaminishi, M., Sugimura, T. and Ushijima, T. 2004. Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett. 212, 203-210.
Kaneda, A., Kaminishi, M., Yanagihara, K., Sugimura, T. and Ushijima, T. 2002. Identification of silencing of nine genes in human gastric cancers. Cancer Res. 62, 6645-6650.
Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., Katayama, T., Araki, M. and Hirakawa, M. 2006. From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res. 34, 354-357.
Kassis, J., Moellinger, J., Lo, H., Greenberg, N. M., Kim, H. G. and Wells, A. 1999. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin. Cancer Res. 5, 2251-2260.
Kaverina, I., Krylyshkina, O. and Small, J. V. 2002. Regulation of substrate adhesion dynamics during cell motility. Int. J. Biochem. Cell Biol. 34, 746-761.
Keller, R. 2005. Cell migration during gastrulation. Curr. Opin. Cell Biol. 17, 533-541.
Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S. M. and Helman, L. J. 2004. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10, 182-186.
Klein, C. A. 2004. Gene expression sigantures, cancer cell evolution and metastatic progression. Cell Cycle 3, 29-31.
Kobayashi, T., Okada, F., Fujii, N., Tomita, N., Ito, S., Tazawa, H., Aoyama, T., Choi, S. K., Shibata, T., Fujita, H. and Hosokawa, M. 2002. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am. J. Pathol. 160, 869-882.
Koon, N., Schneider-Stock, R., Sarlomo-Rikala, M., Lasota, J., Smolkin, M., Petroni, G., Zaika, A., Boltze, C., Meyer, F., Andersson, L., Knuutila, S., Miettinen, M. and El-Rifai, W. 2004. Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 53, 235-240.
Kovar, D. R., Wu, J. Q. and Pollard, T. D. 2005. Profilin-mediated competition between capping protein and formin Cdc12p during cytokinesis in fission yeast. Mol. Biol. Cell 16, 2313-2324.
Kurisu, S., Suetsugu, S., Yamazaki, D., Yamaguchi, H. and Takenawa, T. 2005. RacWAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24, 1309-1319.
Lal, A., Lash, A. E., Altschul, S. F., Velculescu, V., Zhang, L., McLendon, R. E., Marra, M. A., Prange, C., Morin, P. J., Polyak, K., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., Strausberg, R. L. and Riggins, G. J. 1999. A public database for gene expression in human cancers. Cancer Res. 59, 5403-5407.
Lambrechts, A., Kwiatkowski, A. V., Lanier, L. M., Bear, J. E., Vandekerckhove, J., Ampe, C. and Gertler, F. B. 2000. cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J. Biol. Chem. 275, 36143-36151.
Lambrechts, A., Van Troys, M. and Ampe, C. 2004. The actin cytoskeleton in normal and pathological cell motility. Int. J. Biochem. Cell Biol. 6, 1890-1909.
Langbein, S., Lehmann, J., Harder, A., Steidler, A., Michel, M. S., Alken, P. and Badawi, J. K. 2006. Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol. Cancer Res. Treat. 5, 67-72.
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., Ekman, P., DeMarzo, A. M., Tibshirani, R., Botstein, D., Brown, P. O., Brooks, J. D. and Pollack, J. R. 2004. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA 101, 811-816.
LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V. and Gerald, W. L. 2002. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62, 4499-4506.
Lauffenburger, D. A. and Horwitz, A. F. 1996. Cell migration: A physically integrated molecular process. Cell 84, 359-369.
Lawrence, B., Perez-Atayde, A., Hibbard, M. K., Rubin, B. P., Dal, C. P., Pinkus, J. L., Pinkus, G. S., Xiao, S., Yi, E., Fletcher, C. D. and Fletcher, J. A. 2000. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am. J. Pathol. 157, 377-384.
Leavitt, J., Ng, S. Y., Varma, M., Latter, G., Burbeck, S., Gunning, P. and Kedes, L. 1987. Expression of transfected mutant beta-actin genes: Transitions toward the stable tumorigenic state. Mol. Cell. Biol. 7, 2467-2476.
Lee, H. K., Driscoll, D., Asch, H., Asch, B. and Zhang, P. J. 1999. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate 40,14-19.
Lee, Y. G., Macoska, J. A., Korenchuk, S. and Pienta, K. J. 2002. MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4, 291-294.
Lee, Y. J., Mazzatti, D. J., Yun, Z. and Keng, P. C. 2005b. Inhibition of invasiveness of human lung cancer cell line H1299 by over-expression of cofilin. Cell Biol. Int. 29,877-883.
Lee, S. H., Son, M. J., Oh, S. H., Rho, S. B., Park, K., Kim, Y. J., Park, M. S. and Lee, J. H. 2005a. Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res. 65, 137-148.
Lee, S. H., Zhang, W., Choi, J. J., Cho, Y. S., Oh, S. H., Kim, J. W., Hu, L., Xu, J., Liu, J. and Lee, J. H. 2001. Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Oncogene 20, 6700-6706.
Lener, T., Burgstaller, G. and Gimona, M. 2004. The role of calponin in the gene profile of metastatic cells: Inhibition of metastatic cell motility by multiple calponin repeats. FEBS Lett. 556, 221-226.
Li, Y., Tondravi, M., Liu, J., Smith, E., Haudenschild, C. C., Kaczmarek, M. and Zhan, X. 2001. Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 61, 6906-6911.
Lin, C. S., Park, T., Chen, Z. P. and Leavitt, J. 1993. Human plastin genes. Comparative gene structure, chromosome location and differential expression in normal and neoplastic cells. J. Biol. Chem. 268, 2781-2792.
Lin, Y. H., Park, Z. Y., Lin, D., Brahmbhatt, A. A., Rio, M. C., Yates, J. R. and Klemke, R. L. 2004. Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J. Cell Biol. 165, 421-432.
Lin, F., Yu, Y. P., Woods, J., Cieply, K., Gooding, B., Finkelstein, P., Dhir, R., Krill, D., Becich, M. J., Michalopoulos, G., Finkelstein, S. and Luo, J. H. 2001. Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers. Am. J. Pathol. 159, 1603-1612.
Linder, S. and Kopp, P. 2005. Podosomes at a glance. J. Cell Sci. 118, 2079-2082.
Loberg, R. D., Neeley, C. K., Adam-Day, L. L., Fridman, Y., St John, L. N., Nixdorf, S., Jackson, P., Kalikin, L. M. and Pienta, K. J. 2005. Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology. Int. J. Oncol. 26, 1699-1705.
Lorenz, M., Yamaguchi, H., Wang, Y., Singer, R. H. and Condeelis, J. 2004. Imaging sites of N-wasp activity in lamellipodia and invadopodia of carcinoma cells. Curr. Biol. 14, 697-703.
Lukasik, S. M., Zhang, L., Corpora, T., Tomanicek, S., Li, Y., Kundu, M., Hartman, K., Liu, P. P., Laue, T. M., Biltonen, R. L., Speck, N. A. and Bushweller, J. H. 2002. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis. Nat. Struct. Biol. 9, 674-679.
Luo, J. H., Yu, Y. P., Cieply, K., Lin, F., Deflavia, P., Dhir, R., Finkelstein, S., Michalopoulos, G. and Becich, M. 2002. Gene expression analysis of prostate cancers. Mol. Carcinog. 33, 25-35.
Maaser, K., Wolf, K., Klein, C. E., Niggemann, B., Zanker, K. S., Brocker, E. B. and Friedl, P. 1999. Functional hierarchy of simultaneously expressed adhesion receptors: Integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices. Mol. Biol. Cell 10, 3067-3079.
Machesky, L. M., Atkinson, S. J., Ampe, C., Vandekerckhove, J. and Pollard, T. D. 1994. Purification of a cortical complex containing two unconventional actins from Acanthamoeba by affinity chromatography on profilin-agarose. J. Cell Biol. 127, 107-115.
Mahadev, K., Raval, G., Bharadwaj, S., Willingham, M. C., Lange, E. M., Vonderhaar, B., Salomon, D. and Prasad, G. L. 2002. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp. Cell Res. 279, 40-51.
Mareel, M. and Leroy, A. 2003. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83, 337-376.
Martoglio, A. M., Tom, B. D., Starkey, M., Corps, A. N., Charnock-Jones, D. S. and Smith, S. K. 2000. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. Mol. Med. 6, 750-765.
Maul, R. S., Song, Y., Amann, K. J., Gerbin, S. C., Pollard, T. D. and Chang, D. D. 2003. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments. J. Cell Biol. 160, 399-407.
McClatchey, A. I. and Giovannini, M. 2005. Membrane organization and tumorigenesis - The NF2 tumor suppressor, Merlin. Genes Dev. 19, 2265-2277.
McCormack, S. A., Ray, R. M., Blanner, P. M. and Johnson, L. R. 1999. Polyamine depletion alters the relationship of F-actin, G-actin and thymosin beta4 in migrating IEC-6 cells. Am. J. Physiol. 276, 459-468.
McNiven, M. A., Baldassarre, M. and Buccione, R. 2004. The role of dynamin in the assembly and function of podosomes and invadopodia. Front. Biosci. 9, 1944-1953.
Meyer, T. and Brinck, U. 1997. Immunohistochemical detection of vinculin in human rhabdomyosarcomas. Gen. Diagn. Pathol. 142, 191-198.
Mielnicki, L. M., Ying, A. M., Head, K. L., Asch, H. L. and Asch, B. B. 1999. Epigenetic regulation of gelsolin expression in human breast cancer cells. Exp. Cell Res. 249, 161-176.
Mitchison, T. J. and Cramer, L. P. 1996. Actin-based cell motility and cell locomotion. Cell 84, 371-379.
Mueller, M. M. and Fusenig, N. E. 2004. Friends or foes - Bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-849.
Muller-Tidow, C., Diederichs, S., Thomas, M. and Serve, H. 2004. Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 45, S145-S150.
Nabeshima, K., Inoue, T., Shimao, Y., Kataoka, H. and Koono, M. 1999. Cohort migration of carcinoma cells, differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol. Histopathol. 14, 1183-1197.
Nalbant, P., Hodgson, L., Kraynov, V., Toutchkine, A. and Hahn, K. M. 2004. Activation of endogenous Cdc42 visualized in living cells. Science 305, 1615-1619.
Niggli, V. 2005. Regulation of protein activities by phosphoinositide phosphates. Annu. Rev. Cell Dev. Biol. 21, 57-79.
Nikolopoulos, S. N., Spengler, B. A., Kisselbach, K., Evans, A. E., Biedler, J. L. and Ross, R. A. 2000. The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 19, 380-386.
Nishiya, N., Kiosses, W., Han, J. and Ginsberg, M. 2005. An alpha4 integrin-pax- illin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat. Cell Biol. 7, 343-352.
Nixdorf, S., Grimm, M. O., Loberg, R., Marreiros, A., Russell, P. J., Pienta, K. J. and Jackson, P. 2004. Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett. 215, 209-220.
Noske, A., Denkert, C., Schober, H., Sers, C., Zhumabayeva, B., Weichert, W., Dietel, M. and Wiechen, K. 2005. Loss of gelsolin expression in human ovarian carcinomas. Eur. J. Cancer 41, 461-469.
Novy, R. E., Lin, J. L., Lin, C. S. and Lin, J. J. 1993. Human fibroblast tropomyosin isoforms: Characterization of cDNA clones and analysis of tropomyosin isoform expression in human tissues and in normal and transformed cells. Cell Motil. Cytoskeleton 25, 267-281.
Nowak, D., Skwarek-Maruszewska, A., Zemanek-Zboch, M. and MalickaBlaszkiewicz, M. 2005. Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. Acta Biochim. Pol. 52, 461-468.
Ohashi, K., Nagata, K., Maekawa, M., Ishizaki, T., Narumiya, S. and Mizuno, K. 2000. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J. Biol. Chem. 275, 3577-3582.
Ohtani, K., Sakamoto, H., Rutherford, T., Chen, Z., Satoh, K. and Naftolin, F. 1999. Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett. 147, 31-38.
Oien, K. A., Vass, J. K., Downie, I., Fullarton, G. and Keith, W. N. 2003. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 22, 4287-4300.
Oleynikov, Y. and Singer, R. H. 2003. Real-time visualization of ZBP1 association with beta-actin mRNA during transcription and localization. Curr. Biol. 13, 199-207.
Otsubo, T., Iwaya, K., Mukai, Y., Mizokami, Y., Serizawa, H., Matsuoka, T. and Mukai, K. 2004. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod. Pathol. 17, 461-467.
Pantel, K. and Woelfle, U. 2004. Micrometastasis in breast cancer and other solid tumors. J. Biol. Regul. Homeost. Agents 18, 120-125.
Park, P. C., Taylor, M. D., Mainprize, T. G., Becker, L. E., Ho, M., Dura, W. T., Squire, J. and Rutka, J. T. 2003. Transcriptional profiling of medulloblastoma in children. J. Neurosurg. 99, 534-541.
Patel, A. S., Schechter, G. L., Wasilenko, W. J. and Somers, K. D. 1998. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16, 3227-3232.
Pawlak, G., McGarvey, T. W., Nguyen, T. B., Tomaszewski, J. E., Puthiyaveettil, R., Malkowicz, S. B. and Helfman, D. M. 2004. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int. J. Cancer 110, 368-373.
Pederson, T. and Aebi, U. 2005. Nuclear actin extends, with no contraction in sight. Mol. Biol. Cell 16, 5055-5060.
Polet, D., Vandekerckhove, J., Ampe, C. and Lambrechts, A. 2006. Putting the biochemistry of profilins in a cellular context. Curr. Top. Biochem. Res. 8, 11-28.
Pollard, T. D. and Borisy, G. G. 2003. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-465.
Prasad, G. L., Fuldner, R. A. and Cooper, H. L. 1993. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl Acad. Sci. USA 90, 7039-7043.
Prasad, G. L., Masuelli, L., Raj, M. H. and Harindranath, N. 1999. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 18, 2027-2031.
Pugh, C. W. and Ratcliffe, P. J. 2003. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation and cancer pathogenesis. Semin. Cancer Biol. 13, 83-89.
Pulford, K., Lamant, L., Espinos, E., Jiang, Q., Xue, L., Turturro, F., Delsol, G. and Morris, S. W. 2004. The emerging normal and disease-related roles of anaplastic lymphoma kinase. Cell. Mol. Life Sci. 61, 2939-2953.
Qi, Y., Chiu, J. F., Wang, L., Kwong, D. L. and He, Q. Y. 2005. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5, 2960-2971.
Quinlan, M. E., Heuser, J. E., Kerkhoff, E. and Mullins, R. D. 2005. Drosophila Spire is an actin nucleation factor. Nature 433, 382-388.
Raftopoulou, M. and Hall, A. 2004. Cell migration: Rho GTPases lead the way. Dev. Biol. 265, 23-32.
Ramaraj, P., Singh, H., Niu, N., Chu, S., Holtz, M., Yee, J. K. and Bhatia, R. 2004. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. Cancer Res. 64, 5322-5331.
Rao, J. and Li, N. 2004. Microfilament actin remodeling as a potential target for cancer drug development. Curr. Cancer Drug Targets 4, 345-354.
dos Remedios, C. G., Chhabra, D., Kekic, M., Dedova, I. V., Tsubakihara, M., Berry, D. A. and Nosworthy, N. J. 2003. Actin binding proteins: Regulation of cytoskeletal microfilaments. Physiol. Rev. 83, 433-473.
Rho, S. B., Chun, T., Lee, S. H., Park, K. and Lee, J. H. 2004. The interaction between E-tropomodulin and thymosin beta-10 rescues tumor cells from thymosin beta-10 mediated apoptosis by restoring actin architecture. FEBS Lett. 557, 57-63.
Rhodes, D. R., Barrette, T. R., Rubin, M. A., Ghosh, D. and Chinnaiyan, A. M. 2002. Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 62, 4427-4433.
Rhodes, D. R. and Chinnaiyan, A. M. 2005. Integrative analysis of the cancer transcriptome. Nat. Genet. 37(Suppl.), 31-37.
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A. and Chinnaiyan, A. M. 2004. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci. USA 101, 9309-9314.
Robinson, B. W., Musk, A. W. and Lake, R. A. 2005. Malignant mesothelioma. Lancet 366, 397-408.
Rodrigo, J. P., Garcia, L. A., Ramos, S., Lazo, P. S. and Suarez, C. 2000. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 6, 3177-3182.
Roma, A. A. and Prayson, R. A. 2005. Fascin expression in 90 patients with glioblastoma multiforme. Ann. Diagn. Pathol. 9, 307-311.
Rommelaere, H., Waterschoot, D., Neirynck, K., Vandekerckhove, J. and Ampe, C. 2004. A method for rapidly screening functionality of actin mutants and tagged actins. Biol. Proced. Online 6, 235-249.
Ross, A. F., Oleynikov, Y., Kislauskis, E. H., Taneja, K. L. and Singer, R. H. 1997. Characterization of a beta-actin mRNA zipcode-binding protein. Mol. Cell. Biol. 17,2158-2165.
Sadano, H., Inoue, M. and Taniguchi, S. 1992. Differential expression of vinculin between weakly and highly metastatic B16-melanoma cell lines. Jpn. J. Cancer Res. 83,625-630.
Sadano, H., Taniguchi, S. and Baba, T. 1990. Newly identified type of beta actin reduces invasiveness of mouse B16-melanoma. FEBS Lett. 271, 23-27.
Sadano, H., Taniguchi, S., Kakunaga, T. and Baba, T. 1988. cDNA cloning and sequence of a new type of actin in mouse B16 melanoma. J. Biol. Chem. 263, 15868-15871.
Sahai, E. and Marshall, C. J. 2003. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719.
Salgia, R., Li, J. L., Ewaniuk, D. S., Pear, W., Pisick, E., Burky, S. A., Ernst, T., Sattler, M., Chen, L. B. and Griffin, J. D. 1997. BCR/ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Invest. 100, 46-57.
Sanchez-Carbayo, M., Schwarz, K., Charytonowicz, E., Cordon-Cardo, C. and Mundel, P. 2003. Tumor suppressor role for myopodin in bladder cancer: Loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical out- come. Oncogene 22, 5298-5305.
Santelli, G., Califano, D., Chiappetta, G., Vento, M. T., Bartoli, P. C., Zullo, F., Trapasso, F., Viglietto, G. and Fusco, A. 1999. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am. J. Pathol. 155, 799-804.
Sattler, M., Pisick, E., Morrison, P. T. and Salgia, R. 2000. Role of the cytoskeletal protein paxillin in oncogenesis. Crit. Rev. Oncog. 11, 63-76.
Sazawa, A., Watanabe, T., Tanaka, M., Haga, K., Fujita, H., Harabayashi, T., Shinohara, N., Koyanagi, T. and Kuzumaki, N. 2002. Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice. J. Urol. 168, 1182-1187.
Schirenbeck, A., Arasada, R., Bretschneider, T., Schleicher, M. and Faix, J. 2005. Formins and VASPs may co-operate in the formation of filopodia. Biochem. Soc. Trans. 33, 1256-1259.
Schumacher, N., Borawski, J. M., Leberfinger, C. B., Gessler, M. and Kerkhoff, E. 2004. Overlapping expression pattern of the actin organizers Spir-1 and formin-2 in the developing mouse nervous system and the adult brain. Gene Expr. Patterns 4,249-255.
Scoles, D. R., Nguyen, V. D., Qin, Y., Sun, C. X., Morrison, H., Gutmann, D. H. and Pulst, S. M. 2002. Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. Hum. Mol. Genet. 11, 3179-3189.
Scott, J. A., Shewan, A. M., den Elzen, N. R., Louriero, J. J., Gertler, F. B. and Yap, A. S. 2005. Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts. Mol. Biol. Cell 17, 1085-1095.
Segal, E., Friedman, N., Kaminski, N., Regev, A. and Koller, D. 2005. From signatures to models: Understanding cancer using microarrays. Nat. Genet. 37, S38-S45.
Shen, R., Ghosh, D. and Chinnaiyan, A. 2004. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data. BMC Genomics 5, 94.
Shen, Z., Xu, L., Chen, M., Li, E., Li, J., Wu, X. and Zeng, Y. 2003. Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J. Gastroenterol. 9, 1182-1186.
Shestakova, E. A., Wyckoff, J., Jones, J., Singer, R. H. and Condeelis, J. 1999. Correlation of beta-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines. Cancer Res. 59, 1202-1205.
Shieh, D., Godleski, J., Herndon, J., Azuma, T., Mercer, H., Sugarbaker, D. and Kwiatkowski, D. 1999. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: The role of gelsolin expression. Cancer 85, 47-57.
Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D’Amico, A. V., Richie, J. P., Lander, E. S., Loda, M., Kantoff, P. W., Golub, T. R. and Sellers, W. R. 2002. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209.
Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S. and Fusenig, N. E. 1997. Halting angiogenesis suppresses carcinoma cell invasion. Nat. Med. 3, 1222-1227.
Skoble, J., Auerbuch, V., Goley, E. D., Welch, M. D. and Portnoy, D. A. 2001. Pivotal role of VASP in Arp2/3 complex-mediated actin nucleation, actin branch-formation and Listeria monocytogenes motility. J. Cell Biol. 155, 89-100.
Small, J. V. and Resch, G. P. 2005. The comings and goings of actin: Coupling protrusion and retraction in cell motility. Curr. Opin. Cell Biol. 17, 517-523.
Small, J., Stradal, T., Vignal, E. and Rottner, K. 2002. The lamellipodium: Where motility begins. Trends Cell Biol. 12, 112-120.
Smith-Beckerman, D. M., Fung, K. W., Williams, K. E., Auersperg, N., Godwin, A. K. and Burlingame, A. L. 2005. Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer. Mol. Cell. Proteomics 4, 156-168.
Song, Y., Maul, R. S., Gerbin, C. S. and Chang, D. D. 2002. Inhibition of anchorageindependent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton. Mol. Biol. Cell 13, 1408-1416.
Sosne, G., Christopherson, P. L., Barrett, R. P. and Fridman, R. 2005. Thymosinbeta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest. Ophthalmol. Vis. Sci. 46, 2388-2395.
Sosne, G., Xu, L., Prach, L., Mrock, L. K., Kleinman, H. K., Letterio, J. J., Hazlett, L. D. and Kurpakus-Wheater, M. 2004. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp. Cell Res. 293, 175-183.
Sporn, M. B. 1996. The war on cancer. Lancet 347, 1377-1381.
Steelman, L. S., Bertrand, F. E. and McCubrey, J. A. 2004. The complexity of PTEN: Mutation, marker and potential target for therapeutic intervention. Expert Opin. Ther. Targets 8, 537-550.
Stradal, T. E. and Scita, G. 2006. Protein complexes regulating Arp2/3-mediated actin assembly. Curr. Opin. Cell Biol. 18, 4-10.
Strehl, S., Borkhardt, A., Slany, R., Fuchs, U. E., Konig, M. and Haas, O. A. 2003. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene 22, 157-160.
Suyama, E., Wadhwa, R., Kawasaki, H., Yaguchi, T., Kaul, S. C., Nakajima, M. and Taira, K. 2004. LIM kinase-2 targeting as a possible anti-metastasis therapy. J. Gene Med. 6, 357-363.
Suzuki, H., Nagata, H., Shimada, Y. and Konno, A. 1998. Decrease in gamma-actin expression, disruption of actin microfilaments and alterations in cell adhesion systems associated with acquisition of metastatic capacity in human salivary gland adenocarcinoma cell clones. Int. J. Oncol. 12, 1079-1084.
Svitkina, T. M. and Borisy, G. G. 1999. Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia. J. Cell Biol. 145, 1009-1026.
Takano, T., Hasegawa, Y., Miyauchi, A., Matsuzuka, F., Yoshida, H., Kuma, K. and Amino, N. 2002. Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas. Jpn. J. Clin. Oncol. 32, 229-232.
Takeoka, M., Ehara, T., Sagara, J., Hashimoto, S. and Taniguchi, S. 2002. Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells. Eur. J. Cancer 38, 436-442.
Tanaka, M., Mullauer, L., Ogiso, Y., Fujita, H., Moriya, S., Furuuchi, K., Harabayashi, T., Shinohara, N., Koyanagi, T. and Kuzumaki, N. 1995. Gelsolin: A candidate for suppressor of human bladder cancer. Cancer Res. 55, 3228-3232.
Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
Thiery, J. P. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746.
Thor, A. D., Edgerton, S. M., Liu, S., Moore, D. H., II. and Kwiatkowski, D. J. 2001. Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin. Cancer Res. 7, 2415-2424.
Timpson, P., Lynch, D. K., Schramek, D., Walker, F. and Daly, R. J. 2005. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res. 65, 3273-3280.
Tomasetto, C., Moog-Lutz, C., Regnier, C. H., Schreiber, V., Basset, P. and Rio, M. C. 1995. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett. 373, 245-249.
Tong, G. X., Yee, H., Chiriboga, L., Hernandez, O. and Waisman, J. 2005. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum. Pathol. 36, 741-746.
Unwin, R. D., Craven, R. A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, I., Selby, P. and Banks, R. E. 2003. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3, 1620-1632.
Van Ginkel, P. R., Gee, R. L., Walker, T. M., Hu, D. N., Heizmann, C. W. and Polans, A. S. 1998. The identification and differential expression of calcium-binding proteins associated with ocular melanoma. Biochim. Biophys. Acta 1448, 290-297.
Van Troys, M., Dewitte, D., Goethals, M., Carlier, M. F., Vandekerckhove, J. and Ampe, C. 1996. The actin binding site of thymosin beta 4 mapped by mutational analysis. EMBO J. 15, 201-210.
Van Troys, M., Vandekerckhove, J. and Ampe, C. 1999. Structural modules in actin-binding proteins: Towards a new classification. Biochim. Biophys. Acta 1448,323-348.
Vandekerckhove, J., Leavitt, J., Kakunaga, T. and Weber, K. 1980. Coexpression of a mutant beta-actin and the two normal beta- and gamma-cytoplasmic actins in a stably transformed human cell line. Cell 22, 893-899.
Varga, A. E., Stourman, N. V., Zheng, Q., Safina, A. F., Quan, L., Li, X., SosseyAlaoui, K. and Bakin, A. V. 2005. Silencing of the tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. Oncogene 24, 5043-5052.
van ‘t Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R. and Friend, S. H. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
Verrills, N. M., Liem, N. L., Liaw, T. Y., Hood, B. D., Lock, R. B. and Kavallaris, M. 2006. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia - An in vivo study. Proteomics 6, 1681-1694.
Verschueren, H., Dewit, J., De Braekeleer, J., Schirrmacher, V. and De Baetselier, P. 1994. Motility and invasive potency of murine T-lymphoma cells: Effect of microtubule inhibitors. Cell Biol. Int. 18, 11-19.
Vicente-Manzanares, M., Webb, D. J. and Horwitz, A. R. 2005. Cell migration at a glance. J. Cell Sci. 118, 4917-4919.
Vigneswaran, N., Wu, J., Sacks, P., Gilcrease, M. and Zacharias, W. 2005. Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: Possible insights from emerging technology. J. Oral Pathol. Med. 34, 77-86.
Wang, W. S., Chen, P. M., Hsiao, H. L., Wang, H. S., Liang, W. Y. and Su, Y. 2004b. Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal car- cinoma. Oncogene 23, 6666-6671.
Wang, W., Goswami, S., Lapidus, K., Wells, A. L., Wyckoff, J. B., Sahai, E., Singer, R. H., Segall, J. E. and Condeelis, J. S. 2004a. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 64, 8585-8594.
Wang, W., Goswami, S., Sahai, E., Wyckoff, J. B., Segall, J. E. and Condeelis, J. S. 2005a. Tumor cells caught in the act of invading: Their strategy for enhanced cell motility. Trends Cell Biol. 15, 138-145.
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D. and Foekens, J. A. 2005b. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679.
Wang, W., Wyckoff, J. B., Frohlich, V. C., Oleynikov, Y., Huttelmaier, S., Zavadil, J., Cermak, L., Bottinger, E. P., Singer, R. H., White, J. G., Segall, J. E. and Condeelis, J. S. 2002. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62, 6278-6288.
Weigelt, B., Hu, Z., He, X., Livasy, C., Carey, L. A., Ewend, M. G., Glas, A. M., Perou, C. M. and van ‘t Veer, L. J. 2005. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 65, 9155-9158.
Weinstein, B. M. 2005. Vessels and nerves: Marching to the same tune. Cell 120, 299-302.
Welch, D. R. 2004. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res. 6, 61-64.
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr. and Hampton, G. M. 2001. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978.
Wick, W., Grimmel, C., Wild-Bode, C., Platten, M., Arpin, M. and Weller, M. 2001. Ezrin-dependent promotion of glioma cell clonogenicity, motility and invasion mediated by BCL-2 and transforming growth factor-beta2. J. Neurosci. 21, 3360-3368.
Wiesner, S., Legate, K. R. and Fassler, R. 2005. Integrin-actin interactions. Cell. Mol. Life Sci. 62, 1081-1099.
Wilkinson, S., Paterson, H. F. and Marshall, C. J. 2005. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 7, 255-261.
Witke, W., Sharpe, A. H., Hartwig, J. H., Azuma, T., Stossel, T. P. and Kwiatkowski, D. J. 1995. Hemostatic, inflammatory and fibroblast responses are blunted in mice acking gelsolin. Cell 81, 41-51.
Wittenmayer, N., Jandrig, B., Rothkegel, M., Schluter, K., Arnold, W., Haensch, W., Scherneck, S. and Jockusch, B. M. 2004. Tumor suppressor activity of profilin requires a functional actin binding site. Mol. Biol. Cell 15, 1600-1608.
Wolf, K. and Friedl, P. 2005. Functional imaging of pericellular proteolysis in cancer cell invasion. Biochimie 87, 315-320.
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Brocker, E. B. and Friedl, P. 2003a. Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277.
Wolf, K., Muller, R., Borgmann, S., Brocker, E. B. and Friedl, P. 2003b. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102, 3262-3269.
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J. and Condeelis, J. 2004. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029.
Wymann, M. and Marone, R. 2005. Phosphoinositide 3-kinase in disease: Timing, location and scaffolding. Curr. Opin. Cell Biol. 17, 141-149.
Xiao, G. H., Beeser, A., Chernoff, J. and Testa, J. R. 2002. p21-activated kinase links Rac/Cdc42 signaling to merlin. J. Biol. Chem. 277, 883-886.
Xie, J. J., Xu, L. Y., Zhang, H. H., Cai, W. J., Mai, R. Q., Xie, Y. M., Yang, Z. M., Niu, Y. D., Shen, Z. Y. and Li, E. M. 2005. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem. Biophys. Res. Commun. 337, 355-362.
Yager, M. L., Hughes, J. A., Lovicu, F. J., Gunning, P. W., Weinberger, R. P. and O’Neill, G. M. 2003. Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma. Br. J. Cancer 89, 860-863.
Yamada, A., Hirose, K., Hashimoto, A. and Iino, M. 2005a. Real-time imaging of myosin II regulatory light-chain phosphorylation using a new protein biosensor. Biochem. J. 385, 589-594.
Yamada, S., Pokutta, S., Drees, F., Weis, W. I. and Nelson, W. J. 2005b. Deconstructing the cadherin-catenin-actin complex. Cell 123, 889-901.
Yamaguchi, H., Lorenz, M., Kempiak, S., Sarmiento, C., Coniglio, S., Symons, M., Segall, J., Eddy, R., Miki, H., Takenawa, T. and Condeelis, J. 2005. Molecular mechanisms of invadopodium formation: The role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 168, 441-452.
Yamaguchi, H., Wyckoff, J. and Condeelis, J. 2005. Cell migration in tumors. Curr. Opin. Cell Biol. 17, 559-564.
Yamamoto, T., Gotoh, M., Kitajima, M. and Hirohashi, S. 1993. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem. Biophys. Res. Commun. 193, 706-710.
Yang, M., Reynoso, J., Jiang, P., Li, L., Moossa, A. R. and Hoffman, R. M. 2004b. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors. Cancer Res. 64, 8651-8656.
Yang, J., Tan, D., Asch, H. L., Swede, H., Bepler, G., Geradts, J. and Moysich, K. B. 2004a. Prognostic significance of gelsolin expression level and variability in nonsmall cell lung cancer. Lung Cancer 46, 29-42.
Yap, C. T., Simpson, T. I., Pratt, T., Price, D. J. and Maciver, S. K. 2005. The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil. Cytoskeleton 60, 153-165.
Yeo, M., Kim, D. K., Park, H. J., Oh, T. Y., Kim, J. H., Cho, S. W., Paik, Y. K. and Hahm, K. B. 2006. Loss of transgelin in repeated bouts of ulcerative colitisinduced colon carcinogenesis. Proteomics 6, 1158-1165.
Yin, H. L. and Janmey, P. A. 2003. Phosphoinositide regulation of the actin cytoskeleton. Annu. Rev. Physiol. 65, 761-789.
Yoder, B. J., Tso, E., Skacel, M., Pettay, J., Tarr, S., Budd, T., Tubbs, R. R., Adams, J. C. and Hicks, D. G. 2005. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin. Cancer Res. 11, 186-192.
Yokota, S., Yamamoto, Y., Shimizu, K., Momoi, H., Kamikawa, T., Yamaoka, Y., Yanagi, H., Yura, T. and Kubota, H. 2001. Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones 6, 345-350.
Yokoyama, M., Nishi, Y., Yoshii, J., Okubo, K. and Matsubara, K. 1996. Identification and cloning of neuroblastoma-specific and nerve tissue-specific genes through compiled expression profiles. DNA Res. 3, 311-320.
Yu, Y., Khan, J., Khanna, C., Helman, L., Meltzer, P. S. and Merlino, G. 2004a. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 10, 175-181.
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., Michalopoulos, G., Becich, M. and Luo, J. H. 2004b. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22, 2790-2799.
Zaidel-Bar, R., Ballestrem, C., Kam, Z. and Geiger, B. 2003. Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J. Cell Sci. 116, 4605-4613.
Zhang, H. L., Eom, T., Oleynikov, Y., Shenoy, S. M., Liebelt, D. A., Dictenberg, J. B., Singer, R. H. and Bassell, G. J. 2001. Neurotrophin-induced transport of a betaactin mRNP complex increases beta-actin levels and stimulates growth cone motility. Neuron 31, 261-275.
Zicha, D., Allen, W. E., Brickell, P. M., Kinnon, C., Dunn, G. A., Jones, G. E. and Thrasher, A. J. 1998. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101, 659-665.
Zigmond, S. H. 2004. Beginning and ending an actin filament: Control at the barbed end. Curr. Top. Dev. Biol. 63, 145-188.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Van Troys, M., Vandekerckhove, J., Ampe, C. (2008). Actin and Actin-Binding Proteins in Cancer Progression and Metastasis. In: dos Remedios, C.G., Chhabra, D. (eds) Actin-Binding Proteins and Disease. Protein Reviews, vol 8. Springer, New York, NY. https://doi.org/10.1007/978-0-387-71749-4_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-71749-4_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-71747-0
Online ISBN: 978-0-387-71749-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)